Centre for the Study of Host Resistance, Research Institute of the McGill University Health Centre and Departments of Microbiology and Immunology and Medicine, McGill University, Room 610, 3775 University Street, Duff Medical Building, Montréal, QC, Canada H3A2B4.
J Trop Med. 2012;2012:819512. doi: 10.1155/2012/819512. Epub 2011 Nov 3.
Leishmania parasites are able to secure their survival and propagation within their host by altering signalling pathways involved in the ability of macrophages to kill pathogens or to engage adaptive immune system. An important step in this immune evasion process is the activation of host protein tyrosine phosphatase SHP-1 by Leishmania. SHP-1 has been shown to directly inactivate JAK2 and Erk1/2 and to play a role in the negative regulation of several transcription factors involved in macrophage activation. These signalling alterations contribute to the inactivation of critical macrophage functions (e.g., Nitric oxide, IL-12, and TNF-α). Additionally, to interfere with IFN-γ receptor signalling, Leishmania also alters several LPS-mediated responses. Recent findings from our laboratory revealed a pivotal role for SHP-1 in the inhibition of TLR-induced macrophage activation through binding to and inactivating IL-1-receptor-associated kinase 1 (IRAK-1). Furthermore, we identified the binding site as an evolutionarily conserved ITIM-like motif, which we named kinase tyrosine-based inhibitory motif (KTIM). Collectively, a better understanding of the evasion mechanisms utilized by Leishmania parasite could help to develop more efficient antileishmanial therapies in the near future.
利什曼原虫寄生虫能够通过改变参与巨噬细胞杀死病原体或参与适应性免疫系统的信号通路,确保其在宿主中的生存和繁殖。在这种免疫逃避过程中的一个重要步骤是利什曼原虫激活宿主蛋白酪氨酸磷酸酶 SHP-1。已经表明 SHP-1 可以直接使 JAK2 和 Erk1/2 失活,并在负调控参与巨噬细胞激活的几个转录因子中发挥作用。这些信号改变有助于使关键巨噬细胞功能失活(例如,一氧化氮、IL-12 和 TNF-α)。此外,为了干扰 IFN-γ 受体信号,利什曼原虫还改变了几种 LPS 介导的反应。我们实验室的最新发现表明,SHP-1 通过与 IL-1 受体相关激酶 1(IRAK-1)结合并使其失活,在抑制 TLR 诱导的巨噬细胞激活中起关键作用。此外,我们确定了结合位点是一个进化上保守的 ITIM 样基序,我们将其命名为激酶酪氨酸基抑制基序(KTIM)。总的来说,更好地了解利什曼原虫寄生虫利用的逃避机制,可以帮助在不久的将来开发更有效的抗利什曼病疗法。